Break message

Slovenská verzia

Notice of first launch, interruption or termination of supply of a human drug

Date	Holder	Code	Drug	Date from	Subject ▲

18.4.2019	Actavis Group PTC ehf. (ACT-5)	80019	Irbesartan Actavis 300 mg (tbl flm 30x300 mg (fľ.HDPE))	25.4.2019	Z
10.5.2019	CANDE s.r.o. (CRR-SK)	1965B	STALEMED 50 mg/12,5 mg/200 mg (tbl flm 100x50 mg/12,5 mg/200 mg (fľ.HDPE))	29.6.2019	Z
14.6.2019	medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)	51229	Paclimedac 6 mg/ml infúzny koncentrát (con inf 1x16,7 ml/100 mg (liek.inj.skl.))	15.8.2019	Z
13.5.2019	Egis Pharmaceuticals PLC (EGI)	84648	Hotemin 10 mg/g krém (crm der 1x50 g/0,5 g (tuba Al))	1.7.2019	Z
18.4.2019	Actavis Group PTC ehf. (ACT-5)	80020	Irbesartan Actavis 300 mg (tbl flm 60x300 mg (fľ.HDPE))	15.12.2019	Z
31.5.2019	Mylan IRE Healthcare Limited (MYR)	12573	Breakyl 800 mikrogramov (flm buc 28x800 µg (vre.PAN/Al/PA/lamin.pap.-povolenie uvádzať na trh končí dňa 20.05.2019))	20.5.2019	Z
31.5.2019	Mylan IRE Healthcare Limited (MYR)	12514	Breakyl 200 mikrogramov (flm buc 28x200 µg (vre.PAN/Al/PA/lamin.pap.-povolenie uvádzať na trh končí dňa 20.05.2019))	20.5.2019	Z
31.5.2019	Mylan IRE Healthcare Limited (MYR)	02492	Breakyl 200 mikrogramov (flm buc 10x200 µg (vre.PAN/Al/PA/lamin.pap.-povolenie uvádzať na trh končí dňa 20.05.2019))	20.5.2019	Z
18.4.2019	Actavis Group PTC ehf. (ACT-5)	80016	Irbesartan Actavis 300 mg (tbl flm 84x300 mg (blis.PVC/PVDC/Al))	1.10.2019	Z
15.5.2019	GALDERMA INTERNATIONAL (GAD)	5013B	Mirvaso 3 mg/g gél (gel 1x10 g (tuba PE/EAA kopolymér/Al/EAA kopolymér/PE))	20.5.2019	Z
21.5.2019	GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)	2365A	PANADOL PRE DETI JAHODA 24 mg/ml (sus por 1x100 ml (fľ.PET hnedá+dáv.aplikátor-povolenie uvádzať na trh končí dňa 30.06.2019))	30.6.2019	Z
26.4.2019	Mylan Ireland Limited (MNY)	06658	Omeprazol Mylan 20 mg (cps end 30x20 mg (blis.Al/PA/PVC))	30.4.2019	Z
18.4.2019	Actavis Group PTC ehf. (ACT-5)	79737	Irbesartan Actavis 150 mg (tbl flm 28x150 mg (blis.PVC/PVDC/Al))	25.4.2019	Z
10.6.2019	LEO Pharma A/S (LEO-2)	0701B	Daivobet gél (gel der 1x60 g (fľ.HDPE+aplikátor PP))	10.6.2019	Z
15.4.2019	medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)	78211	Irinotecan medac 20 mg/ml (con inf 1x5 ml/100 mg (liek.inj.skl.hnedá))	1.9.2019	Z

« Previous | Next »

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market

From
To